Threshold Pharmaceuticals Announces Presentation and Webcast at the Cantor Fitzgerald Healthcare Conference
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/01/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Cantor Fitzgerald Healthcare Conference on July 8, 2015, at 3:45 p.m. Eastern Time.
A live webcast of the presentation will be available under Webcasts in the Investors section of . A replay of the presentation will be archived on the site for 30 days.
Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the bone marrows of some patients with hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ().
Laura Hansen, Ph.D.
Senior Director, Corporate Communications
Phone: 650-474-8206
E-mail:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.07.2015 - 11:00 Uhr
Sprache: Deutsch
News-ID 404177
Anzahl Zeichen: 0
contact information:
Town:
SOUTH SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Threshold Pharmaceuticals Announces Presentation and Webcast at the Cantor Fitzgerald Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Threshold Pharmaceuticals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
